The University of Kansas Cancer Center is partnering with the national Leukemia & Lymphoma Society to accelerate the development of cancer-fighting drugs, the organizations announced Wednesday.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.